PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsTonsillitis
MeSH D014069 - tonsillitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D010612:Pharyngitis
$
Success rate
D014069: 
Tonsillitis
D000039:Peritonsillar abscess
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAzithromycin Azithromycin  2005-11-14   
Clarithromycin Clarithromycin  2005-05-31   
Taro PharmaceuticalAzithromycin Azithromycin  2019-12-11   
MylanAzithromycin Azithromycin  2007-05-30   
Clarithromycin Clarithromycin  2005-03-11   
Rising PharmaceuticalsAzithromycin Azithromycin  2007-05-30   
Amoxicillin, Lansoprazole, Clarithromycin Lansoprazole, Amoxicillin Clarithromycin  2016-10-07   
Lupin ResearchAzithromycin Azithromycin  2015-05-15   
Clarithromycin Clarithromycin  2015-09-15   
SandozAzithromycin Azithromycin  2005-11-14   
Clarithromycin Clarithromycin  2005-08-25   
Amoxicillin, Lansoprazole, Clarithromycin Lansoprazole, Amoxicillin Clarithromycin  2014-03-04   
Chartwell PharmaceuticalsAzithromycin Azithromycin  2008-02-11   
Clarithromycin Clarithromycin  2007-08-20   
AbbVieClarithromycin Biaxin  1991-10-31   
SanofiTelithromycin Ketek  2001-07-09   
Telithromycin Levviax  2001-07-09   
PfizerAzithromycin, Trovafloxacin Trovan/zithromax Compliance  1998-12-18   
Azithromycin Zithromax  1991-11-01 $406 M Y2023 
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
44%
7/16
Phase 3
88%
23/26
Approved: 7Overall Success rate: 39%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use